KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025)

Johnson & Johnson recorded quarterly Long-Term Debt Issuances of $9.1 billion in Q1 2025, up 913700.0% quarter-over-quarter from $1.0 million in Q3 2024, and up 456800.0% year-over-year from N/an in Q1 2024.

Johnson & Johnson's Long-Term Debt Issuances history runs 15 years deep, the most recent figure standing at $9.1 billion for Q1 2025.

  • In Q1 2025, Long-Term Debt Issuances rose 456800.0% year-over-year to $9.1 billion; the TTM figure through Dec 2025 stood at $9.1 billion (up 37.21% YoY), while the FY2025 annual figure was $9.1 billion, up 37.21% from the prior year.
  • Long-Term Debt Issuances came in at $9.1 billion for Q1 2025 at Johnson & Johnson, up from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $9.1 billion in Q1 2025 to a low of -$7.7 billion in Q4 2023.
  • A 4-year average of $1.8 billion and a median of $2.0 million in 2021 frame the typical range for Long-Term Debt Issuances.
  • Across the five-year window, Long-Term Debt Issuances slumped 99.97% in 2024 and jumped 456800.0% in 2025, its largest moves.
  • Johnson & Johnson's Long-Term Debt Issuances stood at $2.0 million in 2021, then slumped by 383800.0% to -$7.7 billion in 2023, then jumped by 100.01% to $1.0 million in 2024, then soared by 913700.0% to $9.1 billion in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $9.1 billion, $1.0 million, and $6.7 billion for Q1 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 7.99 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 3.96 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn -
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 30, 2025 9.14 Bn
Mar 30, 2025 9.14 Bn
Sep 29, 2024 1.00 Mn
Sep 29, 2024 1.00 Mn
Jun 30, 2024 6.66 Bn
Jun 30, 2024 6.66 Bn
Mar 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn
Oct 1, 2023 -7.67 Bn
Oct 1, 2023 -7.67 Bn
Apr 2, 2023 7.67 Bn
Apr 2, 2023 7.67 Bn
Jan 1, 2023 -1.00 Mn
Jan 1, 2023 -1.00 Mn
Oct 3, 2021 2.00 Mn
Oct 3, 2021 2.00 Mn
Apr 4, 2021 1.00 Mn
Apr 4, 2021 1.00 Mn
Sep 27, 2020 7.43 Bn
Sep 27, 2020 7.43 Bn
Jun 28, 2020 1.00 Mn
Jun 28, 2020 1.00 Mn
Dec 29, 2019 2.00 Mn
Dec 29, 2019 2.00 Mn
Jun 30, 2019 1.00 Mn
Jun 30, 2019 1.00 Mn
Dec 30, 2018 -1.00 Mn
Dec 30, 2018 -1.00 Mn
Sep 30, 2018 3.00 Mn
Sep 30, 2018 3.00 Mn
Jul 1, 2018 1.00 Mn
Jul 1, 2018 1.00 Mn
Apr 1, 2018 2.00 Mn
Apr 1, 2018 2.00 Mn
Dec 31, 2017 4.53 Bn
Dec 31, 2017 4.53 Bn
Oct 1, 2017 1.00 Mn
Oct 1, 2017 1.00 Mn
Apr 2, 2017 4.46 Bn
Apr 2, 2017 4.46 Bn
Jan 1, 2017 12.00 Bn
Jan 1, 2017 12.00 Bn
Apr 3, 2016 7.44 Bn
Apr 3, 2016 7.44 Bn
Mar 29, 2015 3.00 Mn
Mar 29, 2015 3.00 Mn
Dec 28, 2014 2.00 Bn
Dec 28, 2014 2.00 Bn
Sep 28, 2014 4.00 Mn
Sep 28, 2014 4.00 Mn
Jun 29, 2014 -3.00 Mn
Jun 29, 2014 -3.00 Mn
Mar 30, 2014 16.00 Mn
Mar 30, 2014 16.00 Mn
Dec 29, 2013 3.56 Bn
Dec 29, 2013 3.56 Bn
Sep 29, 2013 45.00 Mn
Sep 29, 2013 45.00 Mn
Mar 31, 2013 6.00 Mn
Mar 31, 2013 6.00 Mn
Dec 30, 2012 29.00 Mn
Dec 30, 2012 29.00 Mn
Sep 30, 2012 10.00 Mn
Sep 30, 2012 10.00 Mn
Jul 1, 2012 4.00 Mn
Jul 1, 2012 4.00 Mn
Apr 1, 2012 2.00 Mn
Apr 1, 2012 2.00 Mn
Jan 1, 2012 3.39 Bn
Jan 1, 2012 3.39 Bn
Apr 3, 2011 8.00 Mn
Apr 3, 2011 8.00 Mn
Jun 28, 2009 7.00 Mn
Jun 28, 2009 7.00 Mn
Mar 29, 2009 2.00 Mn
Mar 29, 2009 2.00 Mn